Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Elucid Appoints Mark Miller as Chief Revenue Officer
PRIVATESep 29, 2026
Position
Chief Revenue Officer
Company
Elucid
Mark Miller
BostonManufacturingHealth Care
Description
Elucid has announced the appointment of Mark Miller as chief revenue officer to drive commercial expansion. He will be part of the leadership team and will report directly to CEO Kelly Huang.
Company Information
Company
Elucid
Location
Boston, Massachusetts, United States
About
Elucid is a Boston-based medical technology company using histology-validated software to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid's CTA analysis equips physicians with critical information designed to enable precision medicine. Elucid is the first non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall. Elucid's unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs.
Fundz sees it the moment Elucid changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.